Morgan Stanley Upgrades PTC, Cuts Immuneering, Amicus

Seeking Alpha14:42 ET

Corcept Announces Primary Endpoint Met In Treatment Phase Of CATALYST Trial In Patients With Hypercortisolism And Difficult-To-Control Diabetes

BenzingaDec 12 16:09 ET

Corcept Announces Results From Phase 2 Study Of Dazucorilant In Patients With Amyotrophic Lateral Sclerosis; DAZALS Did Not Meet Its Primary Endpoint, Which Was The Change From Baseline In The ALS Functional Rating Scale-Revised In Patients Who...

BenzingaDec 11 16:08 ET

Raymond James, Cantor Bullish on UniQure Following FDA Update

Seeking AlphaDec 10 13:11 ET

Krystal Biotech Analyst Ratings

BenzingaDec 10 07:12 ET · Ratings

14 Analysts Have This To Say About Arcellx

BenzingaDec 9 10:04 ET